Impact of age on implementation and tolerability of guideline-directed medical therapy in heart failure with reduced ejection fraction
The need for improved implementation strategies to optimize guideline-directed therapy and dosing levels in the ageing HFrEF population is highlighted, with use of GDMT associated with better clinical outcomes, also among older patients.